Back to Search Start Over

[Intermediate and Posterior Uveitis - Classification, diagnostics, complications, and therapeutic algorithms].

Authors :
Heinz C
Baquet-Walscheid K
Source :
Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2023 Dec; Vol. 240 (12), pp. 1433-1447. Date of Electronic Publication: 2023 Nov 17.
Publication Year :
2023

Abstract

Intermediate and posterior uveitis describes a broad variety of different types of intraocular inflammation. Before starting treatment of intermediate or posterior uveitis, a differentiation between infectious or non-infectious uveitis must always be made. Pathognomonic symptoms do not exist, visual loss and vitreous floaters are the most common symptoms. The indication for therapy is influenced by the anatomical localization, the degree of inflammation, an association, complications and the activity of the inflammation. In addition to clinical ophthalmological standard examination, angiography and OCT are the most important investigations to classify and assess the course of inflammation. Macular edema is the most common complication of intermediate or posterior uveitis and should be treated at first onset, recurrence, or worsening. Oral, intravenous, or intravitreal corticosteroids are usually the primary therapy for intermediate or posterior uveitis. Systemic immunosuppression is indicated after steroid failure in non-infectious uveitis.<br />Competing Interests: Erklärung zu finanziellen Interessen Forschungsförderung erhalten: nein; Honorar/geldwerten Vorteil für Referententätigkeit erhalten: ja, von einer anderen Institution (Pharma- oder Medizintechnikfirma usw.); Bezahlter Berater/interner Schulungsreferent/Gehaltsempfänger: ja, von einem/den Sponsor(en) dieser Fortbildungseinheit; Patent/Geschäftsanteile/Aktien (Autor/Partner, Ehepartner, Kinder) an im Bereich der Medizin aktiven Firma: nein; Patent/Geschäftsanteile/Aktien (Autor/Partner, Ehepartner, Kinder) an zu Sponsoren dieser Fortbildung bzw. durch die Fortbildung in ihren Geschäftsinteressen berührten Firma: nein. Erklärung zu nichtfinanziellen Interessen CH: Deutsche Ophthalmologische Gesellschaft; International Uveitis Study Group; International Ocular Inflammation SocietyKBW: DOG, EuDES (jeweils Mitglied); Sektion Uveitis der DOG (Schriftführerin)<br /> (Thieme. All rights reserved.)

Details

Language :
German
ISSN :
1439-3999
Volume :
240
Issue :
12
Database :
MEDLINE
Journal :
Klinische Monatsblatter fur Augenheilkunde
Publication Type :
Academic Journal
Accession number :
37977203
Full Text :
https://doi.org/10.1055/a-2193-2509